Royalty Pharma plc (RPRX)
USD 31.71
(1.6%)
USD 31.71
(1.6%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 5.65 Billion USD | 4.67% |
| 2022 | 5.4 Billion USD | -2.69% |
| 2021 | 5.55 Billion USD | 15.55% |
| 2020 | 4.8 Billion USD | -19.26% |
| 2019 | 5.95 Billion USD | 29.58% |
| 2018 | 4.59 Billion USD | -15.22% |
| 2017 | 5.42 Billion USD | 28.35% |
| 2016 | 4.22 Billion USD | -1.04% |
| 2015 | 4.26 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 5.83 Billion USD | 10.21% |
| 2024 Q1 | 5.29 Billion USD | -6.4% |
| 2023 Q4 | 5.65 Billion USD | 8.92% |
| 2023 Q2 | 4.95 Billion USD | -3.74% |
| 2023 Q3 | 5.19 Billion USD | 4.87% |
| 2023 Q1 | 5.14 Billion USD | -4.81% |
| 2023 FY | 5.65 Billion USD | 4.67% |
| 2022 Q2 | 4.99 Billion USD | -5.87% |
| 2022 FY | 5.4 Billion USD | -2.69% |
| 2022 Q4 | 5.4 Billion USD | -11.67% |
| 2022 Q1 | 5.3 Billion USD | -4.42% |
| 2022 Q3 | 6.11 Billion USD | 22.44% |
| 2021 Q2 | 4.68 Billion USD | -8.39% |
| 2021 FY | 5.55 Billion USD | 15.55% |
| 2021 Q4 | 5.55 Billion USD | 5.01% |
| 2021 Q3 | 5.28 Billion USD | 12.95% |
| 2021 Q1 | 5.11 Billion USD | 6.34% |
| 2020 Q1 | 5.33 Billion USD | -10.44% |
| 2020 FY | 4.8 Billion USD | -19.26% |
| 2020 Q4 | 4.8 Billion USD | 12.88% |
| 2020 Q3 | 4.25 Billion USD | 22.8% |
| 2020 Q2 | 3.46 Billion USD | -34.96% |
| 2019 Q1 | 1.94 Billion USD | 0.0% |
| 2019 Q4 | 5.95 Billion USD | 0.0% |
| 2019 FY | 5.95 Billion USD | 29.58% |
| 2018 FY | 4.59 Billion USD | -15.22% |
| 2017 FY | 5.42 Billion USD | 28.35% |
| 2016 FY | 4.22 Billion USD | -1.04% |
| 2015 FY | 4.26 Billion USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -23.67 Million USD | 23997.77% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 66331.516% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 93440.069% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -42639.444% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 2434.628% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 10274.192% |
| Agenus Inc. | 274.13 Million USD | -1964.039% |
| Fortress Biotech, Inc. | 7.66 Million USD | -73719.635% |
| GlycoMimetics, Inc. | -40.98 Million USD | 13905.914% |
| Novavax, Inc. | -298.29 Million USD | 1996.879% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 1886.619% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 35612.929% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 1600.109% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -900899.204% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -9136.944% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | -202.592% |
| AlloVir, Inc. | -62.69 Million USD | 9125.514% |
| Aptorum Group Limited | 1.35 Million USD | -416855.284% |
| Ardelyx, Inc. | 34.51 Million USD | -16295.094% |
| Bicycle Therapeutics plc | -481.46 Million USD | 1275.216% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -15546.586% |
| Chimerix, Inc. | -25.51 Million USD | 22274.531% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -81102.831% |
| CRISPR Therapeutics AG | -150.84 Million USD | 3851.052% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -40083.758% |
| Precision BioSciences, Inc. | -85.41 Million USD | 6724.839% |
| Dyadic International, Inc. | -6.37 Million USD | 88814.129% |
| Elevation Oncology, Inc. | -19.11 Million USD | 29696.584% |
| Fortress Biotech, Inc. | 7.66 Million USD | -73719.635% |
| GT Biopharma, Inc. | -1.02 Million USD | 554289.52% |
| Alkermes plc | -166.73 Million USD | 3493.492% |
| Immix Biopharma, Inc. | -17.5 Million USD | 32414.92% |
| Innoviva, Inc. | 255.56 Million USD | -2114.043% |
| IO Biotech, Inc. | -140.69 Million USD | 4121.546% |
| Jaguar Health, Inc. | 29.39 Million USD | -19151.727% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 33802.275% |
| ContextLogic Inc. | -232 Million USD | 2538.912% |
| AbCellera Biologics Inc. | -55.94 Million USD | 10214.9% |
| Lantern Pharma Inc. | -21.7 Million USD | 26171.062% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 115363.292% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -132102.687% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -32648.437% |
| MEI Pharma, Inc. | -3.7 Million USD | 152819.973% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 4482.387% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 30652.478% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 55497.249% |
| NextCure, Inc. | -6.47 Million USD | 87459.503% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 5218.897% |
| ChromaDex Corporation | -24.04 Million USD | 23629.088% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 3770.725% |
| Incyte Corporation | -3.17 Billion USD | 278.208% |
| Opthea Limited | 28.15 Million USD | -19995.129% |
| MiMedx Group, Inc. | -33.9 Million USD | 16790.584% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -46419.369% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 10228.661% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -81968.237% |
| Vaxcyte, Inc. | -368.22 Million USD | 1636.627% |
| PDS Biotechnology Corporation | -32.7 Million USD | 17398.885% |
| Pharming Group N.V. | 109.8 Million USD | -5053.068% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 32626.299% |
| Onconetix, Inc. | 5.33 Million USD | -106030.392% |
| Acelyrin, Inc. | -216.9 Million USD | 2708.666% |
| PureTech Health plc | -167.19 Million USD | 3484.196% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -55400.49% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 3329.056% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 244304.103% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 30652.478% |
| ESSA Pharma Inc. | -33.62 Million USD | 16929.293% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -20258.633% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 11304.283% |
| Seer, Inc. | -4.24 Million USD | 133549.882% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 79794.014% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 328306.206% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 96657.594% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 100955.717% |
| Summit Therapeutics Inc. | 34.67 Million USD | -16218.495% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 83273.232% |
| Senti Biosciences, Inc. | 1.74 Million USD | -325088.218% |
| ImmuCell Corporation | 10.99 Million USD | -51383.036% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 7405.619% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -105919.768% |
| Precigen, Inc. | -481 Thousand USD | 1176456.549% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 40936.28% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 88801.599% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 3165.038% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -3398.334% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -5671275.878% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -5003.522% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 23639.855% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 4934.232% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 18676.083% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -45126.401% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 3463.356% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -9075.68% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 74590.192% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 8447.631% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 4320.105% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 19697.794% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 7511018.045% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 18434.116% |
| Aptose Biosciences Inc. | -8.19 Million USD | 69146.659% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 180932.293% |
| Soligenix, Inc. | -4.95 Million USD | 114371.719% |
| Century Therapeutics, Inc. | 847 Thousand USD | -667937.19% |
| Kura Oncology, Inc. | -20.11 Million USD | 28225.435% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 13925.624% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 67476.459% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -310504.959% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 177087.019% |
| Autolus Therapeutics plc | -186.59 Million USD | 3132.318% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 11576.3% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 2151.631% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -16411.833% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -3342.443% |
| GRI Bio, Inc. | -1.79 Million USD | 315499.944% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 63088.378% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 17113.787% |
| IGM Biosciences, Inc. | -72.6 Million USD | 7893.123% |
| INmune Bio, Inc. | -25.41 Million USD | 22367.03% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -3648.418% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 11269.337% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 34921.5% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 196232.414% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -14784.322% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 13838.679% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -17645.884% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -1397.092% |
| Verastem, Inc. | -37.27 Million USD | 15278.591% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 62463.882% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 11010.252% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 37485.365% |
| Histogen Inc. | -7.48 Million USD | 75674.663% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 26287.449% |
| Surrozen, Inc. | -32.66 Million USD | 17422.664% |
| Organovo Holdings, Inc. | -1.5 Million USD | 375566.158% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 134709.044% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -29742.895% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -216194.916% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -136047.137% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 67611.917% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 13124.895% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 38916.83% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 1886.134% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 783729.477% |
| Apollomics, Inc. | -27.39 Million USD | 20754.408% |
| Amarin Corporation plc | -191.04 Million USD | 3061.827% |
| Mesoblast Limited | 55.96 Million USD | -10010.743% |
| Turnstone Biologics Corp. | -14.58 Million USD | 38897.826% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 22471.797% |
| Synaptogenix, Inc. | -28.66 Million USD | 19841.728% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 604616.56% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -11511.005% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 656444.647% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 77972.457% |
| Exelixis, Inc. | -73.05 Million USD | 7845.756% |
| Better Therapeutics, Inc. | -860 Thousand USD | 658038.953% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 23663.382% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 2444.223% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -768618.43% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 76171.152% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -451118.102% |
| Gritstone bio, Inc. | 39.49 Million USD | -14228.374% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 6827.952% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 215068.619% |
| Avid Bioservices, Inc. | 169.72 Million USD | -3233.731% |
| Insmed Incorporated | 721.62 Million USD | -684.107% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 61996.489% |
| MediWound Ltd. | -5.32 Million USD | 106418.583% |
| OmniAb, Inc. | 9.2 Million USD | -61382.94% |
| Alector, Inc. | -35.63 Million USD | 15977.529% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -6481.609% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 114918.892% |
| Zai Lab Limited | -775 Million USD | 830.1% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -1561.486% |
| Aura Biosciences, Inc. | -21.52 Million USD | 26386.992% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 6960.178% |
| Immunic, Inc. | -45.34 Million USD | 12579.654% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 3028.486% |
| Veracyte, Inc. | -203.82 Million USD | 2876.059% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | -786.469% |
| FibroGen, Inc. | 56.76 Million USD | -9867.543% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -63440.427% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 200245.415% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 273400.672% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | -23.265% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 169458.725% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 3509.339% |
| TG Therapeutics, Inc. | 17.86 Million USD | -31577.724% |
| Galecto, Inc. | -21.21 Million USD | 26769.848% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 23889.258% |
| Fortrea Holdings Inc. | 1.56 Billion USD | -260.537% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 23221.424% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 49272.46% |
| XBiotech Inc. | -200.02 Million USD | 2928.812% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 6827.952% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -124861.904% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 16145.926% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 7427.663% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -99324.969% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 3420.292% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 6225.398% |
| Vaxxinity, Inc. | 10.13 Million USD | -55745.588% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | -668.51% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 52649.322% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 8678.863% |
| NexImmune, Inc. | -3.13 Million USD | 180665.399% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 163980.999% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 37543.627% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 20979.244% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 63137.451% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 4542163.014% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 14046.256% |
| Ainos, Inc. | 4.07 Million USD | -138653.676% |
| Pluri Inc. | 22.82 Million USD | -24685.47% |
| Prothena Corporation plc | -608.34 Million USD | 1030.107% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 4864.622% |
| Celularity Inc. | 65.19 Million USD | -8579.667% |
| Rallybio Corporation | -24.1 Million USD | 23576.371% |
| Cue Biopharma, Inc. | -33.81 Million USD | 16831.054% |
| MeiraGTx Holdings plc | -40.3 Million USD | 14139.688% |
| Omeros Corporation | 331.17 Million USD | -1608.54% |
| Humacyte, Inc. | -22.48 Million USD | 25263.546% |
| Immunocore Holdings plc | -358.59 Million USD | 1677.906% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 23124.517% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 18410.977% |
| Blueprint Medicines Corporation | 702.83 Million USD | -705.063% |
| CalciMedica, Inc. | -5.53 Million USD | 102419.62% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 3106.203% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 14232.615% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 17115.833% |
| Pulmatrix, Inc. | -10.41 Million USD | 54417.702% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 94767.475% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 14934.762% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 5179.15% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 9539.266% |
| Cytokinetics, Incorporated | 642.37 Million USD | -780.841% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 97271.132% |
| Nutriband Inc. | -251.65 Thousand USD | 2248507.555% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 16683.941% |
| Vor Biopharma Inc. | 4.3 Million USD | -131487.791% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 193.743% |
| Evogene Ltd. | -19.63 Million USD | 28918.758% |
| ProKidney Corp. | -56.23 Million USD | 10161.66% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 11725.318% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 61355.391% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | -314.859% |
| CorMedix Inc. | -43.05 Million USD | 13242.731% |
| BioLineRx Ltd. | 7.33 Million USD | -77030.248% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 20701.766% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -12161.415% |
| Atai Life Sciences N.V. | -28.55 Million USD | 19913.275% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -253574.128% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 24899.592% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -31804.567% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 7636.93% |
| MediciNova, Inc. | -50.78 Million USD | 11241.952% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 7280.096% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 25153578.551% |
| GeoVax Labs, Inc. | -6.45 Million USD | 87789.995% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 2931.672% |
| Biomea Fusion, Inc. | -166.57 Million USD | 3496.935% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 3261.489% |
| Mereo BioPharma Group plc | -51.46 Million USD | 11093.559% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 6065.876% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 2026.162% |
| Absci Corporation | -72.59 Million USD | 7893.982% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -123821.923% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 2513.559% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 6105.96% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 6012.76% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 14581.291% |
| Allakos Inc. | -24.97 Million USD | 22755.756% |
| Imunon, Inc. | -4.21 Million USD | 134377.972% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 38482.004% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 4278.933% |
| BioAtla, Inc. | -109.01 Million USD | 5290.554% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -768618.43% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 602685.197% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -47186.269% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 26786.2% |
| XOMA Corporation | -29 Million USD | 19611.293% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 34268.327% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 62858.152% |
| aTyr Pharma, Inc. | -7.44 Million USD | 76060.196% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 4639.84% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 2818.181% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 7018.983% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 6199.711% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 658663.823% |
| Akari Therapeutics, Plc | -3.84 Million USD | 147259.298% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -348554.253% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | -309.759% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 476331.657% |
| UroGen Pharma Ltd. | 4.39 Million USD | -128760.738% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -4886.099% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -7862765.123% |
| Orgenesis Inc. | 21.78 Million USD | -25874.454% |
| Entera Bio Ltd. | -10.62 Million USD | 53334.312% |
| GH Research PLC | -78.07 Million USD | 7347.045% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 25487.092% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 21324.633% |
| Xencor, Inc. | 29.64 Million USD | -18987.421% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 287349.494% |
| Replimune Group, Inc. | 1.41 Million USD | -400627.691% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 2310467.567% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 4575.881% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 476331.657% |
| Portage Biotech Inc. | -4.98 Million USD | 113697.169% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 25153578.551% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 8657.326% |
| OncoCyte Corporation | -6.56 Million USD | 86314.765% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -630409.587% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 124303.652% |
| Purple Biotech Ltd. | -14.13 Million USD | 40121.75% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 23918.299% |
| scPharmaceuticals Inc. | -6.54 Million USD | 86551.872% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 33997.79% |
| HilleVax, Inc. | -165.48 Million USD | 3519.207% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 223042.277% |
| Tharimmune, Inc. | -10.93 Million USD | 51842.962% |
| Genprex, Inc. | -6.73 Million USD | 84080.21% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 1634.21% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 6496.422% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 403974.019% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 170686.889% |
| OKYO Pharma Limited | -826.84 Thousand USD | 684418.641% |
| Savara Inc. | 153 Thousand USD | -3698118.954% |
| Curis, Inc. | -23.88 Million USD | 23787.675% |
| Daré Bioscience, Inc. | -5.15 Million USD | 109800.904% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 729247.874% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 91244.894% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -477391.561% |
| BeiGene, Ltd. | -2.25 Billion USD | 351.134% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -45758.694% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 1030.325% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 3148.87% |
| Erasca, Inc. | -37.21 Million USD | 15303.877% |
| bluebird bio, Inc. | 108.57 Million USD | -5111.59% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 439443.563% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -1393.942% |
| DBV Technologies S.A. | -126.98 Million USD | 4555.826% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 439443.563% |
| Moderna, Inc. | -2.9 Billion USD | 294.643% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 54758.762% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 52163.627% |
| Molecular Templates, Inc. | 707 Thousand USD | -800221.782% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 18136.642% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -1532.471% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 6995.122% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 6268.402% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 17633.078% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 16559.958% |
| MacroGenics, Inc. | -66.98 Million USD | 8547.078% |
| RenovoRx, Inc. | -1.17 Million USD | 482476.385% |
| Adicet Bio, Inc. | -138.78 Million USD | 4176.949% |
| Prime Medicine, Inc. | -27.94 Million USD | 20350.796% |
| Aditxt, Inc. | 18.12 Million USD | -31125.158% |
| Adagene Inc. | -87.62 Million USD | 6557.199% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 135938.982% |
| Quantum-Si incorporated | -118.55 Million USD | 4872.62% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -15615.248% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 75804.21% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 11764.382% |
| SciSparc Ltd. | -2.06 Million USD | 274108.475% |
| Vericel Corporation | 1.27 Million USD | -442991.229% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 47284.924% |
| Minerva Neurosciences, Inc. | 41 Million USD | -13699.241% |
| Generation Bio Co. | 31.44 Million USD | -17892.48% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 3326.589% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 18397.95% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -4753.014% |
| Invivyd, Inc. | -198.47 Million USD | 2950.861% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 6368.168% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 236088.768% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 8093.043% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 83005.128% |
| 2seventy bio, Inc. | 181.71 Million USD | -3013.818% |
| ADMA Biologics, Inc. | 90.06 Million USD | -6182.365% |
| Clene Inc. | 3.34 Million USD | -169309.431% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 62397.259% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 26404.1% |
| GeoVax Labs, Inc. | -6.45 Million USD | 87789.995% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 1744.255% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 21862.861% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -3084.782% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 138391.149% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -113020.252% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 108724.976% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 4442.365% |
| Evaxion Biotech A/S | 5.28 Million USD | -106925.571% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 5126.54% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 4410.311% |
| Trevena, Inc. | 2.25 Million USD | -250487.91% |
| Surrozen, Inc. | -32.66 Million USD | 17422.664% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 11084.809% |
| Cingulate Inc. | 3.08 Million USD | -183450.336% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 192754.92% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -78629.303% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 60999.115% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 7233.209% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 4404.442% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 5461.16% |
| Clearmind Medicine Inc. | -3.94 Million USD | 143614.988% |
| Kronos Bio, Inc. | -36.05 Million USD | 15793.89% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -60036.837% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -387950.904% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 10528.847% |
| Statera Biopharma, Inc. | 14.41 Million USD | -39148.86% |
| ImmunityBio, Inc. | 618.22 Million USD | -815.247% |
| Korro Bio, Inc. | -132.94 Million USD | 4356.166% |
| Kineta, Inc. | -4.54 Million USD | 124704.162% |
| BioVie Inc. | -17.73 Million USD | 32009.333% |
| Codexis, Inc. | -43.27 Million USD | 13176.368% |
| Celularity Inc. | 65.19 Million USD | -8579.667% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 178650.805% |
| Celcuity Inc. | 6.78 Million USD | -83312.213% |
| Virax Biolabs Group Limited | -3.36 Million USD | 168253.616% |
| Cibus, Inc. | -8.07 Million USD | 70145.494% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 133896.997% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -123713.457% |
| IN8bio, Inc. | -16.38 Million USD | 34624.834% |
| Kodiak Sciences Inc. | -103.87 Million USD | 5547.196% |
| Annexon, Inc. | -193.75 Million USD | 3020.325% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -15717330.556% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 32434.848% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 161166.752% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | -436.699% |
| Eyenovia, Inc. | 1.25 Million USD | -449432.534% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -20930.571% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 174576.565% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 17118.904% |
| Arcellx, Inc. | -296.95 Million USD | 2005.413% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 29107.869% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 9710.658% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 27399.054% |
| Moolec Science SA | 117.61 Thousand USD | -4810703.802% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 14835.475% |
| Geron Corporation | 14.76 Million USD | -38232.599% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 15022.398% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 4101.015% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 81054.811% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 105608.554% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 4120.632% |
| Humacyte, Inc. | -22.48 Million USD | 25263.546% |
| Structure Therapeutics Inc. | -124.33 Million USD | 4650.683% |
| 89bio, Inc. | -289.05 Million USD | 2057.522% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 22516.112% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 317445.766% |
| Genelux Corporation | -6.89 Million USD | 82115.872% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 18317.827% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -6668.352% |
| Notable Labs, Ltd. | -9.77 Million USD | 57979.245% |
| Liquidia Corporation | -80.17 Million USD | 7157.318% |
| Mustang Bio, Inc. | -3.73 Million USD | 151552.757% |
| Immunovant, Inc. | -635.22 Million USD | 990.749% |
| Quantum-Si incorporated | -118.55 Million USD | 4872.62% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 32315.184% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 136674.342% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -70390.532% |
| Acasti Pharma Inc. | -23 Million USD | 24695.849% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 168139.507% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 34921.5% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 4207.939% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 181666.679% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 25551.039% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 30571.619% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 3442.593% |
| PepGen Inc. | -60.67 Million USD | 9426.314% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 24726.893% |
| United Therapeutics Corporation | -507.7 Million USD | 1214.492% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 29684.205% |
| Solid Biosciences Inc. | -47.75 Million USD | 11949.791% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 656444.647% |
| Immuneering Corporation | -54.94 Million USD | 10398.472% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 134709.044% |
| Silo Pharma, Inc. | -3.52 Million USD | 160649.958% |
| Belite Bio, Inc | -87.27 Million USD | 6583.568% |
| XOMA Corporation | -29 Million USD | 19611.293% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 8103.557% |
| Bionomics Limited | 227 Million USD | -2392.524% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 4965.994% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 223482.353% |
| uniQure N.V. | -102.95 Million USD | 5596.086% |
| Cassava Sciences, Inc. | -121.13 Million USD | 4771.01% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 135938.982% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -13717.184% |
| Forte Biosciences, Inc. | -11.96 Million USD | 47406.036% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 182967.139% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -5337895.283% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 174576.565% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -63440.427% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 76398.207% |
| Altimmune, Inc. | -134.48 Million USD | 4307.303% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -2756.777% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 223482.353% |
| Compugen Ltd. | -12.9 Million USD | 43949.0% |
| Peak Bio, Inc. | 10.34 Million USD | -54621.359% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 1999490.459% |
| Benitec Biopharma Inc. | -50.58 Million USD | 11286.341% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 5523.024% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -28702.622% |
| Zura Bio Limited | -99.8 Million USD | 5769.273% |
| PolyPid Ltd. | 6.17 Million USD | -91606.24% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -7533.938% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -28702.622% |
| Instil Bio, Inc. | 75.35 Million USD | -7408.526% |
| argenx SE | -2.02 Billion USD | 378.892% |
| Immunome, Inc. | -97.02 Million USD | 5931.53% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 25253.479% |
| Verona Pharma plc | -220.44 Million USD | 2666.775% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 7986.867% |
| Shattuck Labs, Inc. | -121.42 Million USD | 4759.931% |
| CervoMed Inc. | -7.79 Million USD | 72708.582% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 3150.299% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 129491.15% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 4395.032% |
| Moolec Science SA | 117.61 Thousand USD | -4810703.802% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 247404.715% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -35490.261% |
| AnaptysBio, Inc. | -18.15 Million USD | 31273.351% |
| Design Therapeutics, Inc. | -18.15 Million USD | 31275.069% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 8139.492% |
| NeurAxis, Inc. | 145.7 Thousand USD | -3883410.638% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -50276.38% |
| Lumos Pharma, Inc. | -28.49 Million USD | 19958.474% |
| Achilles Therapeutics plc | -126.92 Million USD | 4558.002% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 7986.867% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 862997.077% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 27337.521% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -387950.904% |
| Nutriband Inc. | -251.65 Thousand USD | 2248507.555% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 43060.102% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 76152.083% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -1563.235% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -23739.372% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 1364.5% |
| Palisade Bio, Inc. | -12.06 Million USD | 47006.035% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 4132.667% |
| Beam Therapeutics Inc. | -262.72 Million USD | 2253.712% |
| Neurogene Inc. | -131.95 Million USD | 4388.034% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -25836.354% |
| AEON Biopharma, Inc. | -4.88 Million USD | 116048.258% |
| Sesen Bio, Inc. | -112.55 Million USD | 5127.209% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 5766.208% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 241103.998% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 14598.732% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 6894.115% |
| Athira Pharma, Inc. | -88.99 Million USD | 6457.684% |
| Vaccinex, Inc. | -1.28 Million USD | 439407.065% |
| HCW Biologics Inc. | 2.85 Million USD | -197971.99% |
| XOMA Corporation | -29 Million USD | 19611.293% |
| Nektar Therapeutics | 210.24 Million USD | -2591.341% |
| Arvinas, Inc. | -313.8 Million USD | 1903.147% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -348554.253% |
| Merus N.V. | -192.88 Million USD | 3033.512% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -9332.817% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 81654.843% |
| Rezolute, Inc. | -68.16 Million USD | 8400.486% |
| Clene Inc. | 3.34 Million USD | -169309.431% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 43007.978% |
| BeyondSpring Inc. | -13.75 Million USD | 41236.132% |
| Synlogic, Inc. | -6.68 Million USD | 84741.361% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -498866.049% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 67022.235% |
| Peak Bio, Inc. | 10.34 Million USD | -54621.359% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 6965.172% |
| Krystal Biotech, Inc. | -350.23 Million USD | 1715.57% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -4458.53% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 3448.171% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 179321.315% |
| MannKind Corporation | 143.89 Million USD | -3832.116% |
| Ikena Oncology, Inc. | -109.15 Million USD | 5283.659% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 74836.164% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 17194.486% |
| Gossamer Bio, Inc. | 180.35 Million USD | -3037.299% |
| CohBar, Inc. | -5.93 Million USD | 95506.03% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 19120.69% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -123821.923% |
| Legend Biotech Corporation | -949.39 Million USD | 695.986% |
| Mural Oncology plc | -255.84 Million USD | 2311.62% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -17464.101% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 120216.855% |
| Disc Medicine, Inc. | -358.28 Million USD | 1679.284% |
| Champions Oncology, Inc. | 4.81 Million USD | -117486.762% |
| REGENXBIO Inc. | 54.76 Million USD | -10231.352% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 2104275.421% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 3846.606% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 62885.966% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 7112.971% |
| Vaxart, Inc. | -8.24 Million USD | 68760.053% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 11375.964% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 4549.531% |
| Cellectis S.A. | -43.85 Million USD | 13002.235% |
| Longeveron Inc. | -2.9 Million USD | 194676.169% |
| Repare Therapeutics Inc. | -107.85 Million USD | 5346.041% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | -484.304% |
| Inozyme Pharma, Inc. | 12 Million USD | -47036.579% |
| Revolution Medicines, Inc. | -608.2 Million USD | 1030.325% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 460122.358% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 2234.256% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 3870.374% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 36262.044% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 764731.757% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 159.163% |
| Denali Therapeutics Inc. | -74.86 Million USD | 7657.971% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 47284.924% |
| Veru Inc. | 4.77 Million USD | -118274.722% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 50413.667% |
| Cingulate Inc. | 3.08 Million USD | -183450.336% |
| Passage Bio, Inc. | 4.58 Million USD | -123308.397% |
| Context Therapeutics Inc. | -14.44 Million USD | 39258.081% |
| Exicure, Inc. | 5.84 Million USD | -96639.186% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 2556.104% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 14399.406% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -35960.64% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 9719.481% |
| Nuvalent, Inc. | -335.38 Million USD | 1787.088% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -326149.279% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 7696.835% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 63747.638% |
| OmniAb, Inc. | 9.2 Million USD | -61382.94% |
| Anew Medical, Inc. | 1.43 Million USD | -394902.67% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -34440.103% |
| Lipocine Inc. | -4.75 Million USD | 119106.531% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 5251.942% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -37049.728% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 11269.337% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -22631.299% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 84287.993% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 8695.675% |
| Ocugen, Inc. | -32.52 Million USD | 17498.835% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 6712.065% |
| Q32 Bio Inc. | -37.94 Million USD | 15010.601% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 901099.204% |
| Alumis Inc. Common Stock | -13.52 Million USD | 41923.305% |
| Equillium, Inc. | -22.39 Million USD | 25369.181% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 22230.3% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 17442.432% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 2282444.755% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -4121.27% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -176831.676% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -1722667.559% |
| Dominari Holdings Inc. | 195 Thousand USD | -2901579.487% |
| Edesa Biotech, Inc. | -5.26 Million USD | 107530.638% |
| vTv Therapeutics Inc. | -8.91 Million USD | 63554.918% |
| Bio-Techne Corporation | 267.74 Million USD | -2013.292% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 35008.23% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 4891.331% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 67436.368% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 44825.911% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 2408.379% |
| Nkarta, Inc. | 57.29 Million USD | -9774.998% |
| BioCardia, Inc. | 212 Thousand USD | -2668897.642% |
| Iterum Therapeutics plc | 13.43 Million USD | -42006.526% |